Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
7.04
+0.07 (1.00%)
At close: Mar 9, 2026, 4:00 PM EDT
7.24
+0.20 (2.84%)
After-hours: Mar 9, 2026, 7:03 PM EDT
Zura Bio Market Cap
Zura Bio has a market cap or net worth of $667.92 million as of March 9, 2026. Its market cap has increased by 610.39% in one year.
Market Cap
667.92M
Enterprise Value
528.91M
1-Year Change
610.39%
Ranking
Category
Stock Price
$7.04
Market Cap Chart
Since September 3, 2021, Zura Bio's market cap has increased from $167.33M to $667.92M, an increase of 299.18%. That is a compound annual growth rate of 35.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 661.28M | 94.08% |
| Dec 31, 2025 | 340.72M | 108.73% |
| Dec 31, 2024 | 163.23M | -19.82% |
| Dec 29, 2023 | 203.58M | 15.59% |
| Dec 30, 2022 | 176.12M | 3.44% |
| Dec 31, 2021 | 170.26M | 1.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prime Medicine | 710.09M |
| Gyre Therapeutics | 700.76M |
| Jade Biosciences | 692.89M |
| ProKidney | 691.92M |
| Theravance Biopharma | 687.62M |
| Tectonic Therapeutic | 673.52M |
| MiMedx Group | 668.55M |
| Replimune Group | 666.36M |